• by admin
• (0) Comments

Telangana to Launch Next-Gen Life Sciences Policy at Davos

Telangana Chief Minister A. Revanth Reddy announced that the state will unveil its Life Sciences Policy 2026–2030 at the World Economic Forum in Davos, aiming to attract investments in biotech, pharma innovation, and healthcare R&D — positioning the state as a global life sciences destination.

News Source: (The Times of India)

---

Haleon Names Kedar Lele as President – India Subcontinent

Consumer healthcare and OTC pharma leader Haleon has appointed Kedar Lele as its India Subcontinent President, underscoring a strategic push to expand consumer health and over-the-counter pharma in the Indian market.

News Source (eHealth Magazine)

---

Indian Pharma Shifts Toward Specialty Medicines

According to new industry data, Indian pharmaceutical companies are increasingly focusing on specialty therapies (oncology, diabetes, metabolic and autoimmune conditions)as pricing pressure deepens in traditional generics, with differentiated medicines seen as the next growth driver in 2026.

News Source (Business Today)

---

GST Cut on Medicines & Devices to Boost Access

The recent GST Council decision to reduce the GST rate on most medicines and medical devices — lowering taxes to 5% and exempting 36 life-saving drugs — is expected to reduce treatment costs and boost access to key therapies, including cancer and rare disease medicines.

News Sorce (Moneycontrol)

---

📌 Daily Pulse Insight — Why This Matters for India

✔ Policy & positioning: Telangana’s life sciences strategy signals how Indian states are now competing globally for biotech & pharma leadership.

✔ Leadership momentum: Appointment of senior executives in big healthcare firms like Haleon highlights market confidence and strategic growth.

✔ Industry direction: With price pressures on generics, India’s pharma players are pivoting to high-value, differentiated therapies— a sign of maturity.

✔ Access & affordability: The GST reshuffle is a significant policy push that could immediately reduce costs for patients and accelerate adoption of advanced treatments.

---

✨ Follow Daily Pulse for verified, India-centric healthcare & pharma news with real insight — every day. #DailyPulse #IndiaHealthcare #PharmaTrends #LifeSciences #HealthcarePolicy #MedTech #HealthAccess #MarketInsights

---

Disclaimer: The views and opinions expressed in this interview are those of the author and do not reflect the official position of any medical body or organization. 
The author is not a medical doctor; however, the insights shared are based on over a decade of working experience in the healthcare sector start-ups. 
Readers should consult with a qualified healthcare professional for medical advice or information related to their specific situation.

Please follow our page Aristocrat Media for more updates 
For Enquiries connect us on:
marketing@aristocrat-media.com